Estradiol hemihydrate+ Norethisterone acetate
Activelle is a medicine for continuous combined hormone replacement therapy (HRT). The medicine contains two female sex hormones: estrogen and progestogen. Activelle is used for women who have reached menopause, at least one year after their last natural menstrual period. Activelle is used to:
Relieve symptoms occurring after menopause
During menopause, the amount of estrogen produced by the body decreases, which can cause symptoms such as hot flashes. Activelle relieves these symptoms. Activelle should only be prescribed if symptoms significantly interfere with daily life;
Prevent osteoporosis
After menopause, some women develop brittle bones (osteoporosis). All available options should be discussed with your doctor. If you are at increased risk of fractures due to osteoporosis and other medicines are not suitable, Activelle can be used to prevent osteoporosis after menopause. Activelle is indicated for women with an intact uterus and for women who have had their uterus removed.
There is only limited experience with the use of Activelle in women over 65 years of age.
Taking HRT involves risks, which should be considered when deciding whether to start or continue HRT. Experience with HRT in women who have had premature menopause (due to ovarian failure or surgery) is limited. If you are experiencing premature menopause, the risks associated with HRT may be different. You should discuss this with your doctor. Before starting (or resuming) HRT, your doctor should take your medical history, including your family history. Your doctor may decide to perform a physical examination, including a breast examination and/or gynecological examination, if necessary. If you start taking Activelle, you should have regular check-ups (at least once a year). During these check-ups, you should discuss the benefits and risks of continuing to take Activelle with your doctor. You should have regular mammograms as recommended by your doctor.
If you have any of the following conditions, or if you are unsure about any of the conditions listed below, tell your doctor before taking Activelle. Do not start taking Activelle if:
If any of the above conditions occur for the first time while taking Activelle, stop taking it and consult your doctor immediately.
Before starting treatment, tell your doctor if you have ever had any of the following conditions, as they may recur or worsen during treatment with Activelle. Your doctor may need to monitor you more closely:
If you experience any of the following conditions while taking HRT, stop taking Activelle and consult your doctor immediately:
Note:Activelle is not a contraceptive. If it has been less than 12 months since your last menstrual period or you are under 50 years old, you may need to use an additional method of contraception. You should consult your doctor.
Taking estrogen-only HRT increases the risk of endometrial hyperplasia and endometrial cancer. The progestogen in Activelle helps to reduce this additional risk.
During the first 3 to 6 months of taking Activelle, you may experience irregular bleeding or spotting. However, if irregular bleeding:
Data confirms that taking combined estrogen-progestogen HRT or estrogen-only HRT increases the risk of breast cancer. The additional risk depends on how long you take HRT. This additional risk becomes apparent after 3 years of taking HRT. After stopping HRT, the additional risk will decrease over time, but the risk may remain for 10 years or more if HRT lasted more than 5 years. Comparison: In women aged 50-54 who do not take HRT, breast cancer is diagnosed in approximately 13-17 per 1000 women over 5 years. In women aged 50 who start 5-year estrogen-only HRT, the number of cases will be 16-17 per 1000 women (i.e., 0-3 additional cases). In women aged 50 who start 5-year combined estrogen-progestogen HRT, the number of cases will be 21 per 1000 women (i.e., 4-8 additional cases).
You should check your breasts regularly. You should consult your doctor if you notice any of the following changes:
In addition, it is recommended to participate in breast cancer screening programs. It is essential to inform the nurse or medical staff performing the mammography that you are taking HRT, as it may increase breast density, which can affect the mammography result. Not all lumps can be detected during a mammography in areas with increased breast density.
Ovarian cancer is rare, much rarer than breast cancer. Taking estrogen-only or combined estrogen-progestogen HRT is associated with a slightly increased risk of ovarian cancer. The risk of ovarian cancer depends on age. For example, in women aged 50-54 who do not take HRT, ovarian cancer will be diagnosed in approximately 2 per 2000 women over 5 years. In women who have taken HRT for 5 years, it will occur in approximately 3 per 2000 women (i.e., 1 additional case).
The risk of blood clots in the veinsis 1.3 to 3 times higher in women taking HRT compared to those not taking HRT, especially in the first year of taking HRT. Blood clots can be life-threatening and can cause chest pain, shortness of breath, fainting, or even death. The risk of blood clots in the veins is higher if you are older and if you have any of the following factors. You should tell your doctor if:
If you experience symptoms of a blood clot, see "If you experience any of the following conditions while taking HRT". Comparison: In women aged 50-59 who do not take HRT, the estimated number of cases of blood clots in the veins over 5 years is 4-7 per 1000 women. In women aged 50-59 who take combined estrogen-progestogen HRT, the number of cases over 5 years will be 9-12 per 1000 women (i.e., 5 additional cases).
There is no evidence that HRT prevents heart attacks. In women over 60 years old taking combined estrogen-progestogen HRT, there is a slightly increased risk of developing coronary artery disease compared to those not taking HRT.
The risk of stroke is approximately 1.5 times higher in women taking HRT compared to those not taking HRT. The number of additional cases of stroke due to HRT will increase with age. Comparison: In women aged 50-59 who do not take HRT, the estimated number of cases of stroke over 5 years is 8 per 1000 women. In women aged 50-59 who take HRT, the number of cases over 5 years will be 11 per 1000 women (i.e., 3 additional cases).
HRT does not prevent memory loss. There is some evidence of an increased risk of memory loss in women who start HRT after the age of 65. You should consult your doctor.
Certain medicines may affect the efficacy of Activelle, which may lead to irregular bleeding. These include:
Other medicines may increase the effect of Activelle:
Activelle may affect the efficacy of cyclosporin. Tell your doctor or pharmacistabout all medicines you are currently taking or have recently taken, including those obtained without a prescription, herbal medicines, or other natural products. Your doctor will advise you on this.
If you need to have a blood test, tell your doctor or the laboratory staff that you are taking Activelle, as it may affect the results of some tests.
The tablets can be taken with or without food and drink.
Pregnancy:Activelle is for use in postmenopausal women only. If you become pregnant, stop taking Activelle and consult your doctor immediately. Breastfeeding:do not take Activelle while breastfeeding.
The effect of Activelle on the ability to drive and use machines is not known.
Activelle contains lactose monohydrate. If you have been told that you have an intolerance to some sugars, you should consult your doctor before taking Activelle.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
After finishing all 28 tablets in the pack, continue with the next pack without a break. Instructions for using the calendar pack are at the end of this package leaflet, in the section "Instructions for the User". You can start taking Activelle on any day. If you have been taking another HRT product that caused withdrawal bleeding, start taking Activelle immediately after the bleeding has finished. Your doctor will prescribe the lowest dose that will relieve your symptoms, for the shortest time necessary. If you think that the dose of Activelle is too high or too low, you should talk to your doctor.
If you take more Activelle than you should, talk to a doctor or pharmacist. Overdose of Activelle may cause nausea or vomiting.
If you forget to take a tablet, take it within the next 12 hours. If more than 12 hours have passed, skip the missed dose and continue taking the tablets at the usual time the next day. Do not take a double dose to make up for a forgotten dose. If you forget a dose, you may experience bleeding or spotting.
If you want to stop taking Activelle, you should talk to your doctor first. Your doctor will explain the effects of stopping treatment and discuss other possible treatments with you. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
If you are going to have surgery, tell the surgeon that you are taking Activelle. You may need to stop taking Activelle 4 to 6 weeks before surgery to reduce the risk of blood clots (see section 2 "Blood clots in the veins"). Do not start taking Activelle again until your doctor tells you to.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Women taking HRT have an increased risk of developing the following conditions compared to women not taking HRT:
For more information, see section 2 "Important information before taking Activelle".
Hypersensitivity (allergic) reactions are uncommon. Symptoms of hypersensitivity (allergic) reactions may include:
hives, itching, swelling, difficulty breathing, low blood pressure (pale and cold skin, fast heartbeat), dizziness, sweating, which can be symptoms of anaphylactic reaction and/or anaphylactic shock. If you experience any of these symptoms, stop taking Activelle and seek medical help immediately.
If you experience any side effects, including those not listed in this package leaflet, tell your doctor or pharmacist. You can also report side effects directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl. You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and carton after "EXP". The expiry date refers to the last day of that month. Store below 25°C in a dry place. Do not store in a refrigerator. To protect from light, store in the original packaging. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The tablets are white, round, and 6 mm in diameter. The tablets have "NOVO 288" engraved on one side and the Novo Nordisk logo (Apis bull) on the other. Pack sizes:
Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, Denmark
Novo Nordisk Pharma Sp. z o.o., Tel.: 22 444 49 00, Fax: 22 444 49 01
Detailed information on this medicine is available on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: http://www.urpl.gov.pl.
Turn the inner dial until the day of the week is opposite the small plastic flap.
Break off the plastic flap and remove the first tablet.
The next day, turn the transparent dial in the direction of the arrow until it clicks, as indicated by the arrow. Remove the next tablet. Remember to take only one tablet a day.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.